Medtronic Stock Forecast

Stock Price Forecast

According to 29 analysts polled by S&P Global, Medtronic stock has a consensus rating of "Buy" and an average price target of $98.84. The average 1-year stock price forecast is 8.34% higher than the current stock price, while the lowest is $78 (-14.50%) and the highest is $121 (+32.63%).

Price Target: $98.84 (+8.34%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$78	$98.84	$100	$121
Change	-14.50%	+8.34%	+9.61%	+32.63%

Analyst Ratings

The average analyst rating for Medtronic stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	14	14	15	15	16	17
Buy	4	4	2	3	3	3
Hold	13	12	13	12	10	9
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	31	30	30	30	29	29

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Josh Jennings TD Cowen	TD Cowen	Buy Reiterates $100 → $110	Buy	Reiterates	$100 → $110	+20.57%	Aug 28, 2026
Michael Matson Needham	Needham	Buy Reiterates $101 → $114	Buy	Reiterates	$101 → $114	+24.96%	Aug 27, 2026
Larry Biegelsen Wells Fargo	Wells Fargo	Buy Maintains $102	Buy	Maintains	$102	+11.81%	Aug 24, 2026
Robbie Marcus J.P. Morgan	J.P. Morgan	Hold Maintains $86	Hold	Maintains	$86	-5.73%	Aug 20, 2026
Travis Steed Bank of America Securities	Bank of America Securities	Buy Maintains $95	Buy	Maintains	$95	+4.13%	Aug 17, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

38.85B

from 36.36B

6.84%

from 36.36B

Revenue Next Year

40.23B

from 38.85B

3.55%

from 38.85B

EPS This Year

5.95

from 5.53

7.57%

from 5.53

EPS Next Year

6.40

from 5.95

7.67%

from 5.95

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Apr 29, 2022	Apr 28, 2023	Apr 26, 2024	Apr 25, 2025	Apr 24, 2026	Apr 30, 2027
Revenue	31.69B	31.23B	32.36B	33.54B	36.36B	38.85B
Revenue Growth	5.21%	-1.45%	3.64%	3.62%	8.43%	6.84%
Gross Profit	21.66B	20.61B	21.27B	21.93B	23.75B	25.23B
Gross Margin	68.35%	65.98%	65.73%	65.39%	65.31%	64.93%
Operating Income	6.85B	5.57B	6.83B	6.33B	7.27B	9.72B
Net Income	5.04B	3.76B	3.68B	4.66B	4.80B	5.65B
EPS	-	-	-	-	5.53	5.95
EPS Growth	-	-	-	-	0.73%	7.57%
Forward PE	18.03	17.32	14.87	14.64	14.29	15.34
Dividend / Share	2.52	2.72	2.76	2.80	2.84	2.98
Dividend Growth	8.62%	7.94%	1.47%	1.45%	1.43%	4.76%
Free Cash Flow	-1.16B	10.06B	5.72B	4.16B	4.63B	6.54B
No. Analysts	-	-	-	-	-	29

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2027	2028	2029
High	39.0B
Avg	38.9B
Low	38.0B

Revenue Growth

Chart

Revenue Growth	2027	2028	2029
High	7.3%
Avg	6.8%
Low	4.6%

EPS Forecast

Chart

EPS	2027	2028	2029
High	6.02
Avg	5.95
Low	5.88

EPS Growth

Chart

EPS Growth	2027	2028	2029
High	8.9%
Avg	7.6%
Low	6.3%